cbdMD YCBD

$ 0.48 1.99%

Quarterly report 2024-Q2
added 08-14-2024

cbdMD Balance Sheet 2011-2024 | YCBD

Annual Balance Sheet cbdMD

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-521 K	-5.42 M	-25.2 M	-13.1 M	-4.69 M	-4.28 M	75.8 K	763 K	-215 K	-	-	-	-
Long Term Debt	9	125 K	109 K	602 K	-	-	360 K	-	-	-	-	-	-
Long Term Debt Current	1.28 M	1.18 M	1.15 M	1.16 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	2.49 M	4.08 M	14.8 M	24 M	53.2 M	28.5 K	397 K	12 K	4 K	-	-	-	-
Total Current Liabilities	4.67 M	5.29 M	6.92 M	7.69 M	3.71 M	970 K	1.52 M	-	-	-	-	-	-
Total Liabilities	7.16 M	9.37 M	21.7 M	31.7 M	56.9 M	998 K	1.92 M	1.92 M	545 K	-	-	-	-
Deferred Revenue	-	-	-	-	7.34 K	161 K	41.4 K	-	-	-	-	-	-
Retained Earnings	-174 M	-147 M	-73.3 M	-47.4 M	-59.6 M	-6.67 M	-6.26 M	-4.49 M	-1.13 M	-	-	-	-
Total Assets	16.2 M	40.8 M	125 M	111 M	94.5 M	15 M	7.07 M	1.62 M	1.82 M	-	-	-	-
Cash and Cash Equivalents	1.8 M	6.72 M	26.4 M	14.8 M	4.69 M	4.28 M	284 K	34.3 K	-	-	-	-	-
Book Value	9.03 M	31.4 M	103 M	79.2 M	37.6 M	14 M	5.15 M	-293 K	1.28 M	-	-	-	-
Total Shareholders Equity	9.03 M	26.6 M	84.4 M	85.7 M	55.5 M	12.6 M	4.21 M	-293 K	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet cbdMD

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	1.58 M	1.82 M	-	2.4 M	819	-	-	125 K	128 K	77.7 K	93.5 K	109 K	124 K	109 K	5.69 M	264 K	6.01 M	6.01 M	6.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	2.96 M	4.53 M	2.09 M	2.49 M	2.85 M	3.22 M	3.58 M	4.08 M	4.81 M	7.18 M	8.17 M	14.8 M	19.5 M	14.8 M	31.6 M	24 M	24 M	24 M	40.8 M	53.2 M	53.2 M	53.2 M	76.5 M	28.5 K	28.5 K	76.5 M	375 K	397 K	397 K	397 K	-	12 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	10.8 M	11.5 M	8.06 M	7.16 M	7.24 M	7.9 M	9.14 M	9.37 M	10.5 M	13 M	14.9 M	21.7 M	26.2 M	21.7 M	38.4 M	31.7 M	31.7 M	31.7 M	46.3 M	56.9 M	56.9 M	56.9 M	78.3 M	998 K	998 K	78.3 M	1.14 M	1.92 M	1.92 M	1.92 M	-	1.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	550 K	468 K	-	188 K	-	-	-	-	-	-	-	-	755	-	22.4 K	-	-	45.1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-181 M	-180 M	-176 M	-174 M	-157 M	-155 M	-152 M	-147 M	-132 M	-99.2 M	-93.5 M	-73.3 M	-69 M	-73.3 M	-56.9 M	-47.4 M	-47.4 M	-47.4 M	-46.8 M	-59.6 M	-59.6 M	-59.6 M	-11.3 M	-6.67 M	-6.67 M	-7.25 M	-7.39 M	-6.26 M	-6.26 M	-6.26 M	-	-4.49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	13.8 M	14.6 M	15.1 M	16.2 M	33 M	33.7 M	35.7 M	40.8 M	57.1 M	93 M	99.3 M	125 M	116 M	125 M	124 M	111 M	111 M	111 M	102 M	94.5 M	94.5 M	94.5 M	96.4 M	15 M	15 M	96.4 M	15.3 M	7.07 M	7.07 M	15.3 M	2.69 M	1.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.4 M	2.11 M	1.5 M	1.8 M	2.85 M	1.72 M	3.35 M	6.72 M	9.55 M	13.3 M	19.7 M	26.4 M	19 M	26.4 M	28.8 M	14.8 M	14.8 M	28.8 M	3.66 M	4.69 M	4.69 M	3.66 M	8.03 M	4.28 M	4.28 M	8.03 M	8.82 M	284 K	284 K	8.82 M	1.12 M	34.3 K	-	-	-	546 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	3.03 M	3.09 M	7.04 M	9.03 M	25.7 M	25.8 M	26.6 M	31.4 M	46.6 M	80 M	84.4 M	103 M	89.3 M	103 M	85.7 M	79.2 M	79.2 M	79.2 M	55.5 M	37.6 M	37.6 M	37.6 M	18.1 M	14 M	14 M	18.1 M	14.2 M	5.15 M	5.15 M	13.4 M	2.69 M	-293 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	3.03 M	3.09 M	7.04 M	9.03 M	25.7 M	25.8 M	26.6 M	31.4 M	46.6 M	80 M	84.4 M	103 M	89.3 M	85.9 M	85.7 M	85.7 M	85.7 M	85.7 M	55.5 M	55.5 M	55.5 M	55.5 M	18.1 M	14 M	12.6 M	16.8 M	13.4 M	4.21 M	4.21 M	4.21 M	-	363 K	-	-	-	1.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency